Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human Subjects
Alexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndrome
Emily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid load
Matthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 9, 2020
Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
D L Tudorascu, C M Laymon, M Zammit, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia
Andrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Frontiers in Neurology
|
August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
David O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Neuroimage. Clinical
|
June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
Matthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neuroimage. Clinical
|
December 13, 2021
White matter microstructure associations to amyloid burden in adults with Down syndrome
Austin M Bazydlo, Matthew D Zammit, Minjie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials
James M Mountz, Thomas E Yankeelov, Daniel L Rubin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human Subjects
Alexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndrome
Emily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid load
Matthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 9, 2020
Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
D L Tudorascu, C M Laymon, M Zammit, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia
Andrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Frontiers in Neurology
|
August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
David O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Neuroimage. Clinical
|
June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
Matthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neuroimage. Clinical
|
December 13, 2021
White matter microstructure associations to amyloid burden in adults with Down syndrome
Austin M Bazydlo, Matthew D Zammit, Minjie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials
James M Mountz, Thomas E Yankeelov, Daniel L Rubin, et al.
Page
of 9